Journals / Turkish Journal of Biology / 2020 / Cilt: 44 - Sayı: 6

Genome-wide identification of Chiari malformation type I associated candidate genes and chromosomal variations

Pages
449–456
Publication Date
2020-12-14
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The CNV analysis of individuals in both families revealed a potential chromosomal region, 11p15.4, and risk regions that are associated with CMI.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Chiari malformation type I (CMI) is a brain malformation that is characterized by herniation of the cerebellum into the spinal canal.
📊
Key Findings & Data:Chiari malformation type I is highly heterogeneous; therefore, an accurate explanation of the pathogenesis of the disease is often not possible.
💡
Conclusion & Impact:The CNV analysis of individuals in both families revealed a potential chromosomal region, 11p15.4, and risk regions that are associated with CMI.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Chiari type I malformation · neurogenetics · microarray analysis

Abstract

Chiari malformation type I (CMI) is a brain malformation that is characterized by herniation of the cerebellum into the spinal canal. Chiari malformation type I is highly heterogeneous; therefore, an accurate explanation of the pathogenesis of the disease is often not possible. Although some studies showed the role of genetics in CMI, the involvement of genetic variations in CMI pathogenesis has not been thoroughly elucidated. Therefore, in the current study we aim to reveal CMI-associated genomic variations in familial cases. Four CMI patients and 7 unaffected healthy members of two distinct families were analyzed. A microarray analysis of the affected and unaffected individuals from two Turkish families with CMI was conducted. Analyses of single nucleotide variations (SNVs) and copy number variations (CNVs) were performed by calculation of B allele frequency (BAF) and log R ratio (LRR) values from whole genome SNV data. Two missense variations, OLFML2A (rs7874348) and SLC4A9 (rs6860077), and a 5’UTR variation of COL4A1 (rs9521687) were significantly associated with CMI. Moreover, 12 SNVs in the intronic regions of FAM155A, NR3C1, TRPC7, ASTN2, and TRAF1 were determined to be associated with CMI. The CNV analysis showed that the 11p15.4 chromosome region is inherited in one of the families. The use of familial studies to explain the molecular pathogenesis of complex diseases such as CMI is crucial. It has been suggested that variations in OLFML2A, SLC4A9, and COL4A1 play a role in CMI molecular pathogenesis. The CNV analysis of individuals in both families revealed a potential chromosomal region, 11p15.4, and risk regions that are associated with CMI.

🔖

Cite This Article

AVSAR, T., CALİS, S., YİLMAZ, B., OTLUOGLU, G. D., HOLYAVKİN, C., KİLİC, T. (2020). Genome-wide identification of Chiari malformation type I associated candidate genes and chromosomal variations. Turkish Journal of Biology, Cilt: 44 - Sayı: 6, 449–456. https://ajindex.com/articles/197906

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Abdul-Wajid S, 2015, CELL REP, V13, P829, DOI 10.1016/j.celrep.2015.09.035 Beck B, 2006, J INVEST DERMATOL, V126, P1982, DOI 10.1038/sj.jid.5700352 Behesti H, 2018, P NATL ACAD SCI USA, V115, pE9717, DOI 10.1073/pnas.1809382115 Boyles AL, 2006, AM J MED GENET A, V140A, P2776, DOI 10.1002/ajmg.a.31546 Brown PD, 2004,
  2. NEUROSCIENCE, V129, P957, DOI 10.1016/j.neuroscience.2004.07.003 Buell TJ, 2015, NEUROSURG CLIN N AM, V26, P495, DOI 10.1016/j.nec.2015.06.003 Chang JF, 2009, J CELL SCI, V122, P2274, DOI 10.1242/jcs.048975 Chen JQ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174585 del Toro D, 2017,
  3. CELL, V169, P621, DOI 10.1016/j.cell.2017.04.012 Edilova MI, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02969 Furutani Y, 2005, BIOCHEM J, V389, P675, DOI 10.1042/BJ20050120 Gaudet P, 2011, BRIEF BIOINFORM, V12, P449, DOI 10.1093/bib/bbr042 Gong SG, 2009, GENE EXPR PATTERNS, V9, P497, DOI 10.1016/j.gep.2009.07.009 Gould DB, 2006, NEW ENGL J MED, V354, P1489, DOI 10.1056/NEJMoa053727 Hong EP, 2019, J CLIN MED, V8, DOI 10.3390/jcm8020275 Huang SC, 2019, CENT EUR J IMMUNOL, V44, P159, DOI 10.5114/ceji.2019.87067 Keser N, 2019, WORLD NEUROSURG, V121, pE852, DOI 10.1016/j.wneu.2018.09.235 Khoshnoodi J, 2008, MICROSC RES TECHNIQ, V71, P357, DOI 10.1002/jemt.20564 Landrum MJ, 2018, NUCLEIC ACIDS RES, V46, pD1062, DOI 10.1093/nar/gkx1153 Langridge B, 2017, WORLD NEUROSURG, V104, P213, DOI 10.1016/j.wneu.2017.04.082 Lu YC, 2015,
  4. STRUCTURE, V23, P1678, DOI 10.1016/j.str.2015.06.024 Markunas CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061521 Meadows J, 2000, J NEUROSURG, V92, P920, DOI 10.3171/jns.2000.92.6.0920 Merello E, 2017, EUR J HUM GENET, V25, P952, DOI 10.1038/ejhg.2017.71 Nagy L, 2016, TURK NEUROSURG, V26, P315, DOI 10.5137/1019-5149.JTN.10471-14.1 Ortolani F, 2014, HORMONE RES PAEDIAT, V82 PASTERNAK JF, 1980, AM J DIS CHILD, V134, P673, DOI 10.1001/archpedi.1980.02130190041010 Pena-Munzenmayer G, 2016, J GEN PHYSIOL, V147, P423, DOI 10.1085/jgp.201611571 Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491 Qi HH, 2010,
  5. NATURE, V466, P503, DOI 10.1038/nature09261 Schijman E, 2004, CHILD NERV SYST, V20, P323, DOI 10.1007/s00381-003-0878-y Shah AH, 2017, J CRANIOVERTEBRAL JU, V8, P297, DOI 10.4103/jcvjs.JCVJS_138_17 Sistani L, 2013, KIDNEY INT, V83, P63, DOI 10.1038/ki.2012.321 Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003 Tsukada YI, 2010, GENE DEV, V24, P432, DOI 10.1101/gad.1864410 Turk EM, 2013, PLOS ONE,